News
The investigational tuberculosis vaccine M72/AS01E-4 has an acceptable safety profile and robust immunogenicity among ...
1d
Medpage Today on MSNThe Future of ART Regimens for HIV Is in Long-Acting AgentsRecent developments in antiretroviral therapy (ART) include longer-acting therapies that don't require a daily oral pill and ...
Lori Cannon, a renowned Chicago activist and advocate for Chicago's LGBTQ+ community and people living with HIV/AIDS, died ...
Receiving treatment within the first month of life could protect children for at least three years, a study suggests.
Large numbers of vulnerable HIV patients in South Africa are feared to have dropped off medication, in what campaigners warn ...
A single shot of gene therapy given to newborn monkeys appears to shield them from HIV, the virus that causes AIDS, for at ...
22h
ZME Science on MSNThis mRNA HIV Vaccine Produces the Virus-Fighting Antibodies That Have Eluded Researchers for 40 YearsIn a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...
Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.
In Colombia, Afro-descendant women are taking the HIV response into their own hands. Faced with racism, inequality and ...
A London-wide HIV charity has said it could be forced to close if the funding crisis it is facing continues. Positively UK, ...
Delaying long-acting injectable ART for HIV with viremia may lead to thousands of preventable deaths. Modeling supports ...
Despite decades of medical progress, HIV continues to devastate Black communities. The statistics are sobering. The disparities, undeniable.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results